Market Cap 149.32B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.20
Forward PE 8.88
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 29,318,700
Avg Vol 37,990,410
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 30%
Beta 0.43
Analysts Sell
Price Target $29.09

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
topstockalerts
topstockalerts May. 1 at 11:35 PM
Arvinas shares surged after trading resumed on Friday following the U.S. FDA’s approval of VEPPANU (vepdegestrant), a drug developed in partnership with Pfizer, for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer who have already progressed after at least one line of endocrine therapy. The approval is a major milestone because VEPPANU becomes the first-ever PROTAC (proteolysis-targeting chimera) therapy authorized by the FDA. This class of drugs works by degrading disease-causing proteins rather than just blocking them, representing a new approach in targeted cancer treatment. According to Arvinas and Pfizer, the decision also came earlier than expected, being granted ahead of the formal PDUFA action date of June 5, 2026, signaling strong regulatory confidence in the treatment’s safety and efficacy profile. $ARVN $PFE
0 · Reply
amrsamir
amrsamir May. 1 at 10:41 PM
$PFE I found this article for you: - https://www.investing.com/news/stock-market-news/us-fda-approves-pfizer-arvinas-breast-cancer-drug-4654649
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 10:32 PM
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 10:14 PM
$TNXP "Wall Street analysts forecast TNXP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNXP is 55.42 USD with a low forecast of 34.34 USD and a high forecast of 68.25 USD." https://www.alphaspread.com/security/nasdaq/tnxp/analyst-estimates $PFE $LLY $PG $JNJ
1 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm May. 1 at 10:07 PM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile. We also covered these names . $DE $ARM $PFE $NVO
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 May. 1 at 7:57 PM
$PFE and $BMY, chart twinsies!
1 · Reply
Micheal_Pothead
Micheal_Pothead May. 1 at 7:53 PM
$PFE 1/2 average daily volume 🎉🎉🎉
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 1 at 7:47 PM
$PFE what a dog
0 · Reply
JFDI
JFDI May. 1 at 7:25 PM
Gabbard going after Fauci, about time $MRNA $PFE
1 · Reply
Willieberich
Willieberich May. 1 at 7:06 PM
$PFE Dded earlier. No Brainer
0 · Reply
Latest News on PFE
US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 8 hours ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN


Pfizer Stock Is Declining Today: What's Happening?

Apr 28, 2026, 1:23 PM EDT - 3 days ago

Pfizer Stock Is Declining Today: What's Happening?


Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 3 days ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX


Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 8 days ago

Pfizer Transcript: AGM 2026


Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 9 days ago

Pfizer Declares Second-Quarter 2026 Dividend


The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 15 days ago

The Big 3: PFE, V, SYF

SYF V


Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 20 days ago

Big Pharma Is Turning to China for the Newest Drug Ideas


Why Is Pfizer Stock Dropping Tuesday?

Apr 7, 2026, 1:54 PM EDT - 24 days ago

Why Is Pfizer Stock Dropping Tuesday?


5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 5 weeks ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH


China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 2 months ago

China approves Pfizer GLP-1 drug for weight management


Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 2 months ago

Pfizer CEO flags issues with FDA's vaccine leadership


Pfizer Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 10:30 AM EST - 2 months ago

Pfizer Transcript: TD Cowen 46th Annual Health Care Conference


Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 2 months ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug


Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 2 months ago

Pfizer in diabetes drug deal with Sciwind Biosciences


Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 2 months ago

Is There 25% Downside For Pfizer Stock?


Pfizer Earnings Call Transcript: Q4 2025

Feb 3, 2026, 10:00 AM EST - 3 months ago

Pfizer Earnings Call Transcript: Q4 2025


Pfizer Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:45 PM EST - 3 months ago

Pfizer Transcript: 44th Annual J.P. Morgan Healthcare Conference


Pfizer Transcript: Guidance

Dec 16, 2025, 8:00 AM EST - 4 months ago

Pfizer Transcript: Guidance


Pfizer Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 4:00 AM EST - 5 months ago

Pfizer Transcript: Jefferies London Healthcare Conference 2025


Pfizer Transcript: Status Update

Nov 10, 2025, 8:30 AM EST - 6 months ago

Pfizer Transcript: Status Update


Pfizer Earnings Call Transcript: Q3 2025

Nov 4, 2025, 10:00 AM EST - 6 months ago

Pfizer Earnings Call Transcript: Q3 2025


Pfizer Transcript: M&A Announcement

Sep 22, 2025, 8:00 AM EDT - 7 months ago

Pfizer Transcript: M&A Announcement


Pfizer Earnings Call Transcript: Q2 2025

Aug 5, 2025, 10:00 AM EDT - 9 months ago

Pfizer Earnings Call Transcript: Q2 2025


Pfizer Earnings Call Transcript: Q1 2025

Apr 29, 2025, 10:00 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q1 2025


Pfizer Transcript: AGM 2025

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Pfizer Transcript: AGM 2025


Pfizer Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 10:30 AM EST - 1 year ago

Pfizer Transcript: TD Cowen 45th Annual Healthcare Conference


Pfizer Transcript: Status Update

Feb 27, 2025, 10:00 AM EST - 1 year ago

Pfizer Transcript: Status Update


Pfizer Earnings Call Transcript: Q4 2024

Feb 4, 2025, 10:30 AM EST - 1 year ago

Pfizer Earnings Call Transcript: Q4 2024


Pfizer Transcript: Status Update

Dec 18, 2024, 10:00 AM EST - 1 year ago

Pfizer Transcript: Status Update


Pfizer Transcript: Guidance

Dec 17, 2024, 8:30 AM EST - 1 year ago

Pfizer Transcript: Guidance


Pfizer Transcript: UBS Global Healthcare Conference 2024

Nov 13, 2024, 3:30 PM EST - 1 year ago

Pfizer Transcript: UBS Global Healthcare Conference 2024


Pfizer Earnings Call Transcript: Q3 2024

Oct 29, 2024, 10:00 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q3 2024


Pfizer Earnings Call Transcript: Q2 2024

Jul 30, 2024, 10:30 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q2 2024


Pfizer Earnings Call Transcript: Q1 2024

May 1, 2024, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q1 2024


Pfizer Transcript: AGM 2024

Apr 25, 2024, 9:00 AM EDT - 2 years ago

Pfizer Transcript: AGM 2024


Pfizer Transcript: Oncology Innovation Day

Feb 29, 2024, 1:00 PM EST - 2 years ago

Pfizer Transcript: Oncology Innovation Day


Pfizer Earnings Call Transcript: Q4 2023

Jan 30, 2024, 10:00 AM EST - 2 years ago

Pfizer Earnings Call Transcript: Q4 2023


Pfizer Transcript: Investor Update

Dec 13, 2023, 8:30 AM EST - 2 years ago

Pfizer Transcript: Investor Update


Pfizer Earnings Call Transcript: Q3 2023

Oct 31, 2023, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q3 2023


Pfizer Transcript: Investor Update

Oct 16, 2023, 8:00 AM EDT - 2 years ago

Pfizer Transcript: Investor Update


Pfizer Transcript: Citi’s 18th Annual BioPharma Conference

Sep 7, 2023, 10:30 AM EDT - 2 years ago

Pfizer Transcript: Citi’s 18th Annual BioPharma Conference


Pfizer Earnings Call Transcript: Q2 2023

Aug 1, 2023, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q2 2023


Pfizer Earnings Call Transcript: Q1 2023

May 2, 2023, 10:00 AM EDT - 3 years ago

Pfizer Earnings Call Transcript: Q1 2023


Pfizer Transcript: M&A Announcement

Mar 13, 2023, 8:00 AM EDT - 3 years ago

Pfizer Transcript: M&A Announcement


Pfizer Transcript: Cowen Health Care Conference

Mar 7, 2023, 10:30 AM EST - 3 years ago

Pfizer Transcript: Cowen Health Care Conference


Pfizer Transcript: SVB Securities Global Biopharma Conference

Feb 16, 2023, 10:00 AM EST - 3 years ago

Pfizer Transcript: SVB Securities Global Biopharma Conference


Pfizer Earnings Call Transcript: Q4 2022

Jan 31, 2023, 10:00 AM EST - 3 years ago

Pfizer Earnings Call Transcript: Q4 2022


Pfizer Transcript: JPMorgan Healthcare Conference

Jan 9, 2023, 6:00 PM EST - 3 years ago

Pfizer Transcript: JPMorgan Healthcare Conference


Pfizer Earnings Call Transcript: Q3 2022

Nov 1, 2022, 10:00 AM EDT - 3 years ago

Pfizer Earnings Call Transcript: Q3 2022


Pfizer Transcript: Status Update

Oct 20, 2022, 6:48 AM EDT - 3 years ago

Pfizer Transcript: Status Update


Pfizer Transcript: Fireside Chat

Sep 26, 2022, 4:32 AM EDT - 3 years ago

Pfizer Transcript: Fireside Chat


Pfizer Transcript: Status Update

Sep 21, 2022, 8:00 AM EDT - 3 years ago

Pfizer Transcript: Status Update


Pfizer Earnings Call Transcript: Q2 2022

Jul 27, 2022, 8:27 PM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q2 2022


Pfizer Transcript: M&A Announcement

May 10, 2022, 7:11 AM EDT - 4 years ago

Pfizer Transcript: M&A Announcement


Pfizer Earnings Call Transcript: Q1 2022

May 3, 2022, 6:52 AM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q1 2022


Pfizer Earnings Call Transcript: Q4 2021

Feb 8, 2022, 4:39 AM EST - 4 years ago

Pfizer Earnings Call Transcript: Q4 2021


Pfizer Transcript: Investor Call

Dec 16, 2021, 7:00 PM EST - 4 years ago

Pfizer Transcript: Investor Call


Pfizer Transcript: M&A Announcement

Dec 12, 2021, 7:00 PM EST - 4 years ago

Pfizer Transcript: M&A Announcement


Pfizer Earnings Call Transcript: Q3 2021

Nov 1, 2021, 8:00 PM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q3 2021


Pfizer Earnings Call Transcript: Q2 2021

Jul 28, 2021, 2:22 AM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q2 2021


Pfizer Earnings Call Transcript: Q1 2021

May 4, 2021, 10:05 AM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q1 2021


Pfizer Transcript: AGM 2021

Apr 21, 2021, 8:25 PM EDT - 5 years ago

Pfizer Transcript: AGM 2021


Pfizer Transcript: Investor & Analyst Day 2021

Apr 8, 2021, 8:37 PM EDT - 5 years ago

Pfizer Transcript: Investor & Analyst Day 2021


Pfizer Earnings Call Transcript: Q4 2020

Feb 1, 2021, 8:47 PM EST - 5 years ago

Pfizer Earnings Call Transcript: Q4 2020


Pfizer Earnings Call Transcript: Q3 2020

Oct 26, 2020, 10:00 PM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q3 2020


Pfizer Transcript: Investor Day Part 2 2020

Sep 14, 2020, 9:10 PM EDT - 6 years ago

Pfizer Transcript: Investor Day Part 2 2020


Pfizer Transcript: Investor Day Part 1 2020

Sep 13, 2020, 9:05 PM EDT - 6 years ago

Pfizer Transcript: Investor Day Part 1 2020


Pfizer Earnings Call Transcript: Q2 2020

Jul 27, 2020, 9:17 PM EDT - 6 years ago

Pfizer Earnings Call Transcript: Q2 2020


Pfizer Transcript: Analyst & Investor Call

Jun 30, 2020, 9:21 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call


Pfizer Transcript: Analyst & Investor Call

Jun 17, 2020, 9:38 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call


Pfizer Transcript: Analyst & Investor Call

May 14, 2020, 9:48 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call


Pfizer Earnings Call Transcript: Q1 2020

Apr 27, 2020, 9:55 PM EDT - 6 years ago

Pfizer Earnings Call Transcript: Q1 2020


Pfizer Transcript: AGM 2020

Apr 22, 2020, 10:06 PM EDT - 6 years ago

Pfizer Transcript: AGM 2020


Pfizer Earnings Call Transcript: Q4 2019

Jan 27, 2020, 10:09 PM EST - 6 years ago

Pfizer Earnings Call Transcript: Q4 2019


Pfizer Earnings Call Transcript: Q3 2019

Oct 28, 2019, 11:16 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q3 2019


Pfizer Earnings Call Transcript: Q2 2019

Jul 28, 2019, 10:20 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q2 2019


Pfizer Transcript: M&A Announcement

Jun 16, 2019, 10:23 PM EDT - 7 years ago

Pfizer Transcript: M&A Announcement


Pfizer Earnings Call Transcript: Q1 2019

Apr 29, 2019, 10:27 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q1 2019


Pfizer Transcript: Analyst Day 2019

Apr 24, 2019, 10:35 PM EDT - 7 years ago

Pfizer Transcript: Analyst Day 2019


Pfizer Earnings Call Transcript: Q4 2018

Jan 28, 2019, 10:41 PM EST - 7 years ago

Pfizer Earnings Call Transcript: Q4 2018


topstockalerts
topstockalerts May. 1 at 11:35 PM
Arvinas shares surged after trading resumed on Friday following the U.S. FDA’s approval of VEPPANU (vepdegestrant), a drug developed in partnership with Pfizer, for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer who have already progressed after at least one line of endocrine therapy. The approval is a major milestone because VEPPANU becomes the first-ever PROTAC (proteolysis-targeting chimera) therapy authorized by the FDA. This class of drugs works by degrading disease-causing proteins rather than just blocking them, representing a new approach in targeted cancer treatment. According to Arvinas and Pfizer, the decision also came earlier than expected, being granted ahead of the formal PDUFA action date of June 5, 2026, signaling strong regulatory confidence in the treatment’s safety and efficacy profile. $ARVN $PFE
0 · Reply
amrsamir
amrsamir May. 1 at 10:41 PM
$PFE I found this article for you: - https://www.investing.com/news/stock-market-news/us-fda-approves-pfizer-arvinas-breast-cancer-drug-4654649
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 10:32 PM
0 · Reply
TheUnmaker
TheUnmaker May. 1 at 10:14 PM
$TNXP "Wall Street analysts forecast TNXP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNXP is 55.42 USD with a low forecast of 34.34 USD and a high forecast of 68.25 USD." https://www.alphaspread.com/security/nasdaq/tnxp/analyst-estimates $PFE $LLY $PG $JNJ
1 · Reply
UsingAGodAlgorithm
UsingAGodAlgorithm May. 1 at 10:07 PM
$SE (-75% from short entry) We are the best on ST as far as we have seen. Check our profile. We also covered these names . $DE $ARM $PFE $NVO
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 May. 1 at 7:57 PM
$PFE and $BMY, chart twinsies!
1 · Reply
Micheal_Pothead
Micheal_Pothead May. 1 at 7:53 PM
$PFE 1/2 average daily volume 🎉🎉🎉
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 1 at 7:47 PM
$PFE what a dog
0 · Reply
JFDI
JFDI May. 1 at 7:25 PM
Gabbard going after Fauci, about time $MRNA $PFE
1 · Reply
Willieberich
Willieberich May. 1 at 7:06 PM
$PFE Dded earlier. No Brainer
0 · Reply
pasuny
pasuny May. 1 at 6:32 PM
$PFE This company is cursed because they're selling evil drugs to innocent people. Very dirty and filthy, smells very bad just like fermented Napa cabbage aka kimchi.
0 · Reply
reyofhope
reyofhope May. 1 at 6:19 PM
$PFE this trades like a savings account .
2 · Reply
StocktwitsNews
StocktwitsNews May. 1 at 5:44 PM
ARVN Stock Jumps 10% After FDA Approves Breast Cancer Drug A Month Ahead Of Schedule $ARVN $PFE https://stocktwits.com/news/equity/markets/arvn-stock-gains-fda-approval-breast-cancer-drug-pfizer/cZQVgmpReen
0 · Reply
stockjusthave
stockjusthave May. 1 at 5:34 PM
$PFE How many approvals, how many pipelines, how many years same price. Is this a stock or secured bond Pfizer, Arvinas breast cancer therapy approved by the FDA May 01, 2026, 1:21 PM ETPfizer Inc. (PFE) Stock, ARVN StockGHBy: Dulan Lokuwithana, SA News Editor The U.S. Food and Drug Administration on Friday approved vepdegestrant, a breast cancer therapy developed by Pfizer (PFE) and Arvinas (ARVN) under the brand name Veppanu.
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 1 at 5:04 PM
$PFE fantastic news, LLY is green
1 · Reply
notreload_ai
notreload_ai May. 1 at 4:58 PM
FDA approved $PFE $ARVN Veppanu pill for advanced breast cancer with ESR1 mutation, helping hormone-resistant cases. https://notreload.xyz/xy/fda-approves-veppanu-first-protac-for-esr1-breast-cancer/
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 1 at 4:56 PM
$PFE totally controlled
0 · Reply
Typecheck
Typecheck May. 1 at 4:17 PM
$PFE If you bought the stock 5 years ago, the net return is 0. Amazing. Bourla still has a job. Who would think this is a good CEO?
0 · Reply
chartistmind
chartistmind May. 1 at 3:49 PM
$PFE 3 years stuck at 25. What garbage.
0 · Reply
Makingmillions192
Makingmillions192 May. 1 at 3:45 PM
$LEXX $LLY $MRK $NVO $PFE Lexaria is collaborating with a major pharma company’s business development team on their oral delivery solution for GLP-1.
0 · Reply
MrPeanutEsquire
MrPeanutEsquire May. 1 at 3:28 PM
$PFE If Pfizer has taught me anything, its that you should always chase lottery ticket tech stocks that might make money in the future and dont buy profitable companies on sale
0 · Reply
LongLTC
LongLTC May. 1 at 3:04 PM
$PFE Bargain at these levels!
0 · Reply